Bausch Health (BHC) reported second-quarter 2026 consolidated revenue of $2.85 billion, up 13% from $2.53 billion a year earlier. GAAP net income was $260 million, while GAAP net income attributable to Bausch Health was $258 million.

The company reported diluted earnings per share attributable to Bausch Health of $0.68, compared with $0.40 in the prior-year period. Bausch Health also raised its 2026 revenue and adjusted EBITDA guidance.

• Second-quarter consolidated operating income was $740 million, up from $444 million a year earlier.
• Consolidated adjusted EBITDA attributable to Bausch Health was $1.075 billion, up 28% on a reported basis.
• Cash from operating activities was $671 million, up 132% from $289 million in the second quarter of 2025.
• Full-year 2026 revenue guidance was updated to $10.790 billion to $11.040 billion.
• Bausch Health excluding Bausch + Lomb reported revenue of $1.458 billion, up 16% from the prior-year period.

$BHC Insider Trading Activity

$BHC insiders have traded $BHC stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $BHC stock by insiders over the last 6 months:

• FRANK D. LEE sold 24,456 shares for an estimated $132,796
• SEANA CARSON (EVP, General Counsel) has made 0 purchases and 3 sales selling 19,664 shares for an estimated $115,039.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$BHC Hedge Fund Activity

We have seen 91 institutional investors add shares of $BHC stock to their portfolio, and 90 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• NATIONAL BANK OF CANADA /FI/ removed 4,931,952 shares (-92.8%) from their portfolio in Q1 2026, for an estimated $26,632,540
• NUVEEN, LLC added 3,464,801 shares (+1036.9%) to their portfolio in Q1 2026, for an estimated $18,709,925
• ACADIAN ASSET MANAGEMENT LLC added 2,669,082 shares (+120.8%) to their portfolio in Q1 2026, for an estimated $14,413,042
• GEODE CAPITAL MANAGEMENT, LLC added 2,505,189 shares (+145.3%) to their portfolio in Q1 2026, for an estimated $13,528,020
• ROYAL BANK OF CANADA added 2,262,894 shares (+24.9%) to their portfolio in Q1 2026, for an estimated $12,219,627
• GENDELL JEFFREY L added 1,671,565 shares (+128.8%) to their portfolio in Q1 2026, for an estimated $9,026,451
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 1,528,438 shares (-56.1%) from their portfolio in Q1 2026, for an estimated $8,253,565

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Read full article here »